Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
QLS-111 by Qlaris Bio for Open-Angle Glaucoma: Likelihood of Approval
QLS-111 is under clinical development by Qlaris Bio and currently in Phase II for Open-Angle Glaucoma. According to GlobalData, Phase...
Data Insights
QLS-111 by Qlaris Bio for Ocular Hypertension: Likelihood of Approval
QLS-111 is under clinical development by Qlaris Bio and currently in Phase II for Ocular Hypertension. According to GlobalData, Phase...